Jump to main content
Jump to site search

Issue 1, 2015
Previous Article Next Article

Antiviral drug discovery: broad-spectrum drugs from nature

Author affiliations

Abstract

Covering: up to April 2014

The development of drugs with broad-spectrum antiviral activities is a long pursued goal in drug discovery. It has been shown that blocking co-opted host-factors abrogates the replication of many viruses, yet the development of such host-targeting drugs has been met with scepticism mainly due to toxicity issues and poor translation to in vivo models. With the advent of new and more powerful screening assays and prediction tools, the idea of a drug that can efficiently treat a wide range of viral infections by blocking specific host functions has re-bloomed. Here we critically review the state-of-the-art in broad-spectrum antiviral drug discovery. We discuss putative targets and treatment strategies, with particular focus on natural products as promising starting points for antiviral lead development.

Graphical abstract: Antiviral drug discovery: broad-spectrum drugs from nature

Back to tab navigation

Publication details

The article was received on 18 Jun 2014 and first published on 15 Oct 2014


Article type: Review Article
DOI: 10.1039/C4NP00085D
Author version
available:
Download author version (PDF)
Nat. Prod. Rep., 2015,32, 29-48

  •   Request permissions

    Antiviral drug discovery: broad-spectrum drugs from nature

    J. P. Martinez, F. Sasse, M. Brönstrup, J. Diez and A. Meyerhans, Nat. Prod. Rep., 2015, 32, 29
    DOI: 10.1039/C4NP00085D

Search articles by author

Spotlight

Advertisements